Nature Communications (May 2023)

Prioritization of potential causative genes for schizophrenia in placenta

  • Gianluca Ursini,
  • Pasquale Di Carlo,
  • Sreya Mukherjee,
  • Qiang Chen,
  • Shizhong Han,
  • Jiyoung Kim,
  • Maya Deyssenroth,
  • Carmen J. Marsit,
  • Jia Chen,
  • Ke Hao,
  • Giovanna Punzi,
  • Daniel R. Weinberger

DOI
https://doi.org/10.1038/s41467-023-38140-1
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 17

Abstract

Read online

Abstract Our earlier work has shown that genomic risk for schizophrenia converges with early life complications in affecting risk for the disorder and sex-biased neurodevelopmental trajectories. Here, we identify specific genes and potential mechanisms that, in placenta, may mediate such outcomes. We performed TWAS in healthy term placentae (N = 147) to derive candidate placental causal genes that we confirmed with SMR; to search for placenta and schizophrenia-specific associations, we performed an analogous analysis in fetal brain (N = 166) and additional placenta TWAS for other disorders/traits. The analyses in the whole sample and stratifying by sex ultimately highlight 139 placenta and schizophrenia-specific risk genes, many being sex-biased; the candidate molecular mechanisms converge on the nutrient-sensing capabilities of placenta and trophoblast invasiveness. These genes also implicate the Coronavirus-pathogenesis pathway and showed increased expression in placentae from a small sample of SARS-CoV-2-positive pregnancies. Investigating placental risk genes for schizophrenia and candidate mechanisms may lead to opportunities for prevention that would not be suggested by study of the brain alone.